Medically reviewed by Drugs.com. Last updated on Oct 13, 2022.
HYDREA is used alone or in conjunction with other antitumor agents or radiation therapy to treat neoplastic diseases. Individualize treatment based on tumor type, disease state, response to treatment, patient risk factors, and current clinical practice standards.
Base all dosage on the patient’s actual or ideal weight, whichever is less.
HYDREA is a cytotoxic drug. Follow applicable special handling and disposal procedures [see References (15)].
Swallow HYDREA capsules whole. Do NOT open, break, or chew capsules because HYDREA is a cytotoxic drug.
Prophylactic administration of folic acid is recommended [see Warnings and Precautions (5.8)].
Monitor blood counts at least once a week during HYDREA therapy. Severe anemia must be corrected before initiating therapy with HYDREA.
Dose Modifications for Toxicity
Monitor for the following and reduce the dose or discontinue HYDREA accordingly:
- Myelosuppression [see Warnings and Precautions (5.1)]
- Cutaneous vasculitis [see Warnings and Precautions (5.5)]
Consider dose modifications for other toxicities.
Dose Modifications for Renal Impairment
Reduce the dose of HYDREA by 50% in patients with measured creatinine clearance of less than 60 mL/min or with end-stage renal disease (ESRD) [see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)].
|Recommended HYDREA Initial Dose
(mg/kg once daily)
<60 or ESRD*
* On dialysis days, administer HYDREA to patients following hemodialysis.
Close monitoring of hematologic parameters is advised in these patients.
More about Hydrea (hydroxyurea)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- During pregnancy
- Generic availability
- Drug class: antimetabolites
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.